Literature DB >> 10896065

Lactulose-mannitol intestinal permeability test in children with diarrhea caused by rotavirus and cryptosporidium. Diarrhea Working Group, Peru.

Y Zhang1, B Lee, M Thompson, R Glass, R I Cama, D Figueroa, R Gilman, D Taylor, C Stephenson.   

Abstract

BACKGROUND: The relationship between intestinal permeability and acute secretory diarrheal syndromes caused by rotavirus and Cryptosporidium parvum in infants less than 36 months of age was studied using the lactulose-mannitol excretion assay.
METHODS: An oral solution containing 0.4 g/kg lactulose and 0.1 g/kg mannitol was administered to 15 infants with rotavirus, 7 with Cryptosporidium infection and a control group of 7 with secretory diarrhea admitted to the Oral Rehydration Unit of the National Children's Hospital in Lima, Peru. Urinary sugar excretion was measured using an enzymatic spectrophotometric method. The ratio of urinary excretion of lactulose to mannitol was used to measure intestinal mucosal permeability, with higher ratios indicative of increased intestinal permeability. Infants in all three groups were retested 20 days after the initial test.
RESULTS: The (mean +/- SE) lactulose:mannitol (L:M) excretion ratios during the acute phase (day 1) of diarrhea in infants with rotavirus or Cryptosporidium and control infants were 0.67 +/- 0.1, 0.76 +/- 0.16, and 0.26 +/- 0.04, respectively. In the convalescent phase (day 20) the ratios were 0.19 +/- 0.02, 0.28 +/- 0.05, and 0.29 +/- 0.07, respectively. Significant reductions in L:M ratios were noted in rotavirus patients between days 1 and 20 (paired t-test; P < 0.01), Cryptosporidium patients between days 1 and 20 (paired t-test; P < 0.05), and between control subjects on day 1 and rotavirus patients on day 1 and Cryptosporidium patients on day 1 (unpaired t-tests; P < 0.05 for both). There were no significant differences in control subjects between days 1 and 20, control subjects and rotavirus patients on day 20, or control subjects and Cryptosporidium patients on day 20.
CONCLUSIONS: The results indicate that increased intestinal permeability caused by rotavirus or cryptosporidium infections in Peruvian infants less than 36 months of age is a significant but reversible phenomenon. The temporal relationship observed in the current study and the contribution of such alterations in intestinal mucosal integrity to the burden of diarrheal disease and the development of malnutrition in developing countries is discussed.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10896065     DOI: 10.1097/00005176-200007000-00006

Source DB:  PubMed          Journal:  J Pediatr Gastroenterol Nutr        ISSN: 0277-2116            Impact factor:   2.839


  23 in total

1.  Intestinal mucosal permeability of severely underweight and nonmalnourished Bangladeshi children and effects of nutritional rehabilitation.

Authors:  Md Iqbal Hossain; Baitun Nahar; Jena D Hamadani; Tahmeed Ahmed; Anjan Kumar Roy; Kenneth H Brown
Journal:  J Pediatr Gastroenterol Nutr       Date:  2010-11       Impact factor: 2.839

2.  A randomized, double-blind, placebo-controlled trial of rifaximin, a nonabsorbable antibiotic, in the treatment of tropical enteropathy.

Authors:  Indi Trehan; Robert J Shulman; Ching-Nan Ou; Kenneth Maleta; Mark J Manary
Journal:  Am J Gastroenterol       Date:  2009-06-02       Impact factor: 10.864

3.  Early Childhood Diarrhea Predicts Cognitive Delays in Later Childhood Independently of Malnutrition.

Authors:  Relana Pinkerton; Reinaldo B Oriá; Aldo A M Lima; Elizabeth T Rogawski; Mônica O B Oriá; Peter D Patrick; Sean R Moore; Benjamin L Wiseman; Mark D Niehaus; Richard L Guerrant
Journal:  Am J Trop Med Hyg       Date:  2016-09-06       Impact factor: 2.345

4.  Association of enteric parasitic infections with intestinal inflammation and permeability in asymptomatic infants of São Tomé Island.

Authors:  Marisol Garzón; Luis Pereira-da-Silva; Jorge Seixas; Ana Luísa Papoila; Marta Alves; Filipa Ferreira; Ana Reis
Journal:  Pathog Glob Health       Date:  2017-03-10       Impact factor: 2.894

Review 5.  Zinc and gastrointestinal disease.

Authors:  Sonja Skrovanek; Katherine DiGuilio; Robert Bailey; William Huntington; Ryan Urbas; Barani Mayilvaganan; Giancarlo Mercogliano; James M Mullin
Journal:  World J Gastrointest Pathophysiol       Date:  2014-11-15

Review 6.  The cell biology of cryptosporidium infection.

Authors:  Steven P O'Hara; Xian-Ming Chen
Journal:  Microbes Infect       Date:  2011-03-31       Impact factor: 2.700

7.  PPAR-alpha Contributes to the Anti-Inflammatory Activity of Verbascoside in a Model of Inflammatory Bowel Disease in Mice.

Authors:  Emanuela Esposito; Emanuela Mazzon; Irene Paterniti; Roberto Dal Toso; Giovanna Pressi; Rocco Caminiti; Salvatore Cuzzocrea
Journal:  PPAR Res       Date:  2010-06-30       Impact factor: 4.964

8.  Expression of tumor necrosis factor alpha and interleukin 1 beta in jejuna of volunteers after experimental challenge with Cryptosporidium parvum correlates with exposure but not with symptoms.

Authors:  P Robinson; P C Okhuysen; C L Chappell; D E Lewis; I Shahab; A Janecki; A C White
Journal:  Infect Immun       Date:  2001-02       Impact factor: 3.441

9.  Treatment of Cryptosporidium: What We Know, Gaps, and the Way Forward.

Authors:  Hayley Sparks; Gayatri Nair; Alejandro Castellanos-Gonzalez; A Clinton White
Journal:  Curr Trop Med Rep       Date:  2015-08-01

Review 10.  Non-invasive investigation in patients with inflammatory joint disease.

Authors:  Elisabetta Dal Pont; Renata D'Incà; Antonino Caruso; Giacomo-Carlo Sturniolo
Journal:  World J Gastroenterol       Date:  2009-05-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.